A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Sanofi stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 4,260 shares of SNY stock, worth $208,484. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,260
Previous 4,334 1.71%
Holding current value
$208,484
Previous $210,000 16.67%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$48.54 - $58.53 $3,591 - $4,331
-74 Reduced 1.71%
4,260 $245,000
Q2 2024

Aug 13, 2024

SELL
$45.39 - $50.36 $38,672 - $42,906
-852 Reduced 16.43%
4,334 $210,000
Q1 2024

Apr 30, 2024

BUY
$45.75 - $52.48 $55,815 - $64,025
1,220 Added 30.76%
5,186 $252,000
Q3 2023

Oct 17, 2023

BUY
$50.95 - $55.2 $3,464 - $3,753
68 Added 1.74%
3,966 $212,000
Q3 2022

Oct 26, 2022

BUY
$37.22 - $100.5 $4,652 - $12,562
125 Added 3.31%
3,898 $148,000
Q1 2021

May 11, 2021

SELL
$45.46 - $50.51 $4,636 - $5,152
-102 Reduced 2.63%
3,773 $186,000
Q4 2020

Feb 09, 2021

BUY
$45.3 - $51.62 $175,537 - $200,027
3,875 New
3,875 $188,000
Q3 2020

Oct 20, 2020

SELL
$49.47 - $53.77 $186,650 - $202,874
-3,773 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$40.83 - $45.43 $9,921 - $11,039
-243 Reduced 6.05%
3,773 $167,000
Q4 2018

Feb 13, 2019

BUY
$41.48 - $45.59 $7,673 - $8,434
185 Added 4.83%
4,016 $174,000
Q1 2018

May 15, 2018

SELL
$38.98 - $45.76 $2,377 - $2,791
-61 Reduced 1.57%
3,831 $154,000
Q4 2017

Feb 08, 2018

BUY
$42.86 - $50.61 $2,485 - $2,935
58 Added 1.51%
3,892 $167,000
Q3 2017

Nov 08, 2017

BUY
$47.04 - $50.34 $2,869 - $3,070
61 Added 1.62%
3,834 $191,000
Q2 2017

Aug 15, 2017

BUY
N/A
3,773
3,773 $181,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $123B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.